Mark A. Scheper

High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma

Carla Hebert, Kathleen Norris, Mark A. Scheper et al. · Molecular Cancer · 2007 · 275 citations · Full text

Microbial interactions and differential protein expression in<i>Staphylococcus aureus–Candida albicans</i>dual-species biofilms

Brian M. Peters, Mary Ann Jabra‐Rizk, Mark A. Scheper et al. · FEMS Immunology & Medical Microbiology · 2010 · 275 citations · Full text

Pathogenic Microbiology, Microbial Pathogens, Bacteriology +17

Farnesol-Induced Apoptosis in <i>Candida albicans</i>

Mark E. Shirtliff, Bastiaan P. Krom, Roelien A. M. Meijering et al. · Antimicrobial Agents and Chemotherapy · 2009 · 227 citations · Full text

Farnesol-induced Apoptosis, Phytoalexin, Antifungal Agent +15

Oral health status of 207 head and neck cancer patients before, during and after radiotherapy

Bruno Correia Jham, Patrícia Reis, Erika Miranda et al. · Clinical Oral Investigations · 2007 · 172 citations

Oral Health Status, Oncology, Neck Cancer Patients +9

Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate‐associated osteonecrosis

Mark A. Scheper, Ashraf Badros, Risa Chaisuparat et al. · British Journal of Haematology · 2008 · 154 citations · Full text

Immunology, Cell Death, Osteoporosis +17